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Abstract
Background: Obstructive Sleep Apnea (OSA) is associated with medical and neurobehavioral morbidity across the lifespan.
Positive airway pressure (PAP) treatment has demonstrated efficacy in treating OSA and has been shown to improve
daytime functioning in adults, but treatment adherence can be problematic. There are nearly no published studies
examining functional outcomes such as academic functioning in adolescents treated with PAP. This study was conducted as
an initial step towards determining whether PAP treatment improves daytime functioning among adolescents with OSA.
Methods: Self-reported academic grades, self- and parent-reported academic quality of life, and objectively-measured
attention were assessed before and after PAP was clinically initiated in a sample of 13 obese adolescents with OSA, as well
as 15 untreated obese Controls without OSA. Based on adherence data, the treated group was divided into PAP Users (n=6)
and Non-Adherent participants (n=7).
Results: Though demographically similar, the three groups significantly differed in how their academic performance and
attention scores changed from baseline to follow-up. Non-Adherent participants showed worsening functioning over time,
while PAP Users showed stable or improved functioning, similar to controls.
Conclusion: Although many adolescents prescribed PAP for OSA are non-adherent to the treatment, those who adhere to
treatment can display improved attention and academic functioning.
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Introduction
Obstructive Sleep Apnea (OSA) is a nocturnal breathing
disorder associated with neurobehavioral deficits in young children
and adults [1,2]. Less is known about adolescents with OSA, but
we recently reported that this group shows attention deficits and
diminished academic grades [3]. Young children whose OSA is
treated with adenotonsillectomy can show improved daytime
functioning, though the long-term impact of pediatric OSA
remains unclear [1]. In adults, surgical interventions are less
effective, so positive airway pressure (PAP) therapy is often
prescribed. PAP therapy requires that patients wear a snug-fitting
nasal interface attached to a blower that creates a pneumatic
‘‘stent’’ to maintain airway patency during sleep. When used
properly, PAP therapy can dramatically improve OSA in adults
[4] and children [5]. However, adherence with PAP therapy is
often a concern. This is particularly true when PAP is prescribed
for adolescents with OSA, many of whom are obese and therefore
unlikely to achieve cure via adenotonsillectomy [6]. Adolescents
are notorious for diminished adherence to medical regimens and,
indeed, adolescents prescribed PAP for OSA tend to have poor
treatment adherence [7].
Adults who adhere to PAP therapy show gains in daytime
functioning, including improved alertness, quality of life, and at
least some aspects of neurobehavioral functioning [4,8]. To our
knowledge, only one published study has examined the impact of
PAP therapy on the daytime functioning in children with OSA;
Marcus and colleagues demonstrated improved daytime sleepiness
after 6 months of PAP treatment, but no change in other
functional outcomes, including behavior, temperament, and
school performance [5]. That study did not specifically assess
attention, did not differentiate participants who were adherent to
treatment from those who were not, and used a school
performance measure that was of unproven sensitivity to OSA.
These methodological factors might have obscured changes in
functioning for those individuals who were more adherent to PAP.
Given the scarce evidence supporting PAP effectiveness in
improving daytime functioning in adolescents, clinicians can find it
challenging to convince already skeptical adolescents of the
potential benefits of PAP therapy, which requires time to establish
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e16924and diligence to maintain. Instead, surgical options that do not
require long-term patient adherence are often undertaken, despite
research to suggest that surgery has lower success and higher
complication rates in obese adolescents, a rapidly-growing
population at very high risk for OSA [6,9,10]. If the field is to
improve care, large-scale investigation of the impact of PAP
therapy on OSA-linked morbidity is needed. However, sample size
limitations make it difficult to publish the preliminary studies
needed to justify the expense of larger-scale work. Even Marcus et
al.’s study, conducted over 3 sites, reported on only 21 subjects [5].
Other studies of pediatric PAP adherence have had larger samples,
but most subjects had a heterogeneous mix of neurodevelopmental
conditions [7,11] which effectively ruled out standardized
assessments of change in daytime functioning.
The current single-site study was designed to build the case for
larger-scale work in this area, and to help inform clinical care. This
paper examines whether PAP improves academic functioning and
attention among adolescents who have OSA related to obesity, not
to a neurological or developmental disorder that could indepen-
dently impact daytime functioning. We prospectively studied the
functioning of obese adolescents with OSA who were clinically
prescribed PAP therapy, as well as untreated obese controls
without OSA. We hypothesized that adolescent PAP users would
show a more positive change in academic performance and
attention as compared to those nonadherent to PAP, and to
untreated controls.
Methods
Ethics Statement
All methods were approved and overseen by the Institutional
Review Board at Cincinnati Children’s Hospital Medical Center.
After receiving print and verbal information regarding the study,
all participants provided written documentation of informed assent
and parents of participants provided written documentation of
informed consent.
Participants
The 35 recruited participants were a subset from a study of
neurobehavioral functioning in overweight 10–16-year-olds with
and without OSA [3]. All were obese and were without a history of
neurological illness/injury, neurodevelopmental disorder, condi-
tion involving daytime hypoxia, or ongoing psychiatric medication
use. After a baseline inpatient polysomnogram (see [3]), partici-
pants who showed evidence of OSA were referred for clinical
follow-up. For the current study, we enrolled 18 patients who were
clinically diagnosed with OSA and who, at their doctors’
prescriptions, had PAP therapy titrated during a second overnight
polysomnogram to optimally correct obstructive respiratory
events, respiratory arousals, and excessive work of breathing. To
account for practice and exposure effects, we also recruited a
Control Group of 17 obese participants who did not have OSA
and consequently received no airway treatment. Of those enrolled,
5 patients prescribed PAP and 2 controls were lost to follow-up
due to subjects moving out of the region (1 control, 1 prescribed
PAP) or the family not responding to multiple calls and letters.
This left 13 patients prescribed PAP and 15 controls for analyses.
For the patients whose PAP therapy was clinically-prescribed,
PAP machines and interfaces were supplied by various medical
equipment providers depending on each patient’s location and
insurance provider. At the time of this study, the PAP units varied,
so there was no consistent objective index of treatment adherence.
In order to obtain a consistent measure of PAP adherence across
patients, we called parents monthly for 4 months after starting
treatment to ask how many nights per week the participant had
used PAP, the number of hours of PAP use during nights it was
used, and the hours of nightly sleep typically obtained.
Information from the month 3 and 4 reports was used to estimate
adherence for this study. Adherence rates were calculated as the
percent of sleep time during which PAP was used. Assessed in this
way, adherence rates were quite variable across participants,
ranging from 0–88%. Because we were interested in evaluating
functional outcomes in participants who were reported to be more
adherent with PAP treatment relative to those who were less
adherent, we split the treatment group at the median of 21%,
resulting in a Non-Adherent Group (n=7) and a PAP Users
Group (n=6).
Measures
All participants underwent neurobehavioral evaluations at
baseline and at 4-months after PAP initiation, or an equivalent
time period for controls. The 4-month follow-up point was set to
allow adequate time for stable adherence patterns to develop and
to exceed the length of the conventional 10- to 12-week academic
grading period in the United States (US) school system. In fact,
because at our center at the time of this study there was a delay
between initial OSA diagnosis and initiation of PAP treatment, the
follow-up evaluation occurred on average 8.6 months after the
baseline assessment (range: 6–15 months).
The neurobehavioral evaluation was comprised of office-based
tests and parent- and self-report questionnaires. For the purposes
of the present study, we focused on measures that (a) were repeated
across both assessment time points and (b) addressed constructs
found to be vulnerable to OSA in our baseline, cross-sectional
study [3]. Academic Performance was assessed in two ways.
First, subjects self-reported their grades based upon the US
convention of using the letters ‘‘A’’ through ‘‘F’’, in which ‘‘A’’
grades denote the highest marks and ‘‘F’’ grades denote failing
marks. To allow for variation in marks across subjects and to
increase meaningful variance while retaining a single outcome
variable, we adopted an 8-option scale based upon Wolfson and
Carskadon’s epidemiological work [12] that allows for ‘‘mixed’’
grades (e.g., ‘‘mostly A’’, ‘‘A and B’’, ‘‘mostly B’’, ‘‘mostly B and
C’’, etc) and that was then converted to the US 4-point convention
(A=4.0, A and B=3.5, B=3.0, etc; see [3]). Second, we obtained
parent- and self-reported scholastic functioning on the well-
validated Pediatric Quality of Life measure (Peds-QL 4.0 Generic)
[13]. Attention was assessed via the age-normed Total Correct z-
score on the computerized Gordon Diagnostic System, a validated
sustained attention test [14]. For this task, test-takers view a screen
on which single-digit numbers are flashed at 1 second intervals for
9 minutes; test-takers are asked to push a large button immediately
after the second number of a pre-specified 2-number series, and to
refrain from responding at other times.
Results
Chi-square and Kruskal-Wallace tests were used to compare all
three groups and to contrast the two PAP-prescribed groups. Non-
parametric tests were conservatively used because of the small
sample and concerns about violated assumptions of parametric
statistics. As shown in Table 1, the three groups did not
significantly differ on sex, race, age, baseline scholastic functioning
or vigilance, or time between baseline and follow-up assessments.
The two PAP groups also did not differ in severity of OSA or
obesity. As predicted, the PAP Users Group displayed a more
favorable change than the Non-Adherent Group across all four
outcome measures (Table 1). Although parent questionnaire
Adolescent PAP Adherence and Outcomes
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followed the same pattern as the other outcome measures. As
illustrated in Figure 1, the Non-Adherent Group showed a decline
in school performance and attention from baseline to follow-up,
while the PAP Users Group displayed stable or improved scores
over time, similar to Controls. All of the PAP Users had stable or
improved grades, while about half of the Non-Adherent group’s
grades declined. 83% of PAP Users had improved attention over
time, whereas 86% of Non-Adherent participants’ attention
worsened.
Discussion
The present findings represent an important step in demon-
strating the potential efficacy of PAP intervention in reversing two
of the most prominent daytime effects of adolescent OSA:
inattention and poor school performance. Impressively, a group
of adolescents with even modest levels of PAP adherence (57% on
average) displayed stable or improved attention and school
performance, whereas a similar group of non-adherent adolescents
trended towards declines in academic and school performance.
This potential utility of even partial adherence to PAP therapy
mirrors adult findings, in which improved sleepiness and quality of
life have been observed in groups in which PAP use averages
around 50% of each night [4,8]. It remains unknown whether,
beyond such group averages, greater individual PAP usage results
in greater gains in daytime functioning.
Present findings extend prior work that suggested an improve-
ment in daytime sleepiness after PAP treatment in pediatric
populations [5]. There are multiple potential mechanisms by
which such gains might occur. When titrated properly and used
consistently, PAP markedly reduces or eliminates the sleep
disruption and gas exchange abnormalities that characterize
OSA [5]; both have been proposed to be key mechanisms that
underlie OSA-related neurobehavioral morbidity, and there is
evidence to support both as sufficient but not necessary causes of
such morbidity [1]. Attempts within the current sample to quantify
sleep quantity and quality using objective actigraphy before and
after treatment were regrettably unsuccessful because of missing
data related to poor adherence with wearing the actigraph units at
one or both measurement time points.
Although present results provide important evidence that can be
used to support and justify future larger-scale research, findings are
considered preliminary. The sample was small, in part due to
substantial loss of subjects to follow-up. This has also been
observed in the limited other studies in this area [5], suggesting
that future work will need to institute a highly comprehensive
subject retention protocol or an initial ‘‘run-in’’ period (e.g.,
demonstration of PAP use at sub-optimal pressure prior to
titration) to screen prospective subjects. Our reliance on parent-
report of adherence is a further limitation, though if anything the
lack of precision associated with such reports would tend to
obscure findings, suggesting that current findings may in fact be
conservative. Despite concerns that parent-report might overesti-
mate adherence, PAP adherence still tended to be poor in our
sample, similar to or slightly worse than that which has been
observed among other adolescent samples via objective monitors
[5,7,11]. Assignment to the groups was not random, and though
Table 1. Cross-Group Comparisons on Descriptive Variables and Change Over Time in School Performance and Attention.
Group
Difference across all 3
groups?
Non-Adherent vs PAP
Users
Controls Non-Adherent PAP Users x
2 (df=2) p x
2 (df=1) p
Descriptive Variables
% Boys 33 71 67 3.62 .164 .03 .853
% Caucasian 20 14 50 2.63 .269 1.94 .164
Age (yrs) 13.361.9 14.461.5 14.861.8 2.78 .250 .18 .668
Baseline Body Mass Index (BMI) 34.964.4 45.4615.1 42.466.1 6.13 .047 .00 .999
Baseline BMI z-score for age and sex 2.3660.18 2.6460.28 2.6460.17 8.91 .012 .02 .886
Baseline Obstructive Index 1.761.2 9.365.7 10.066.8 11.48 .003 .02 .886
Baseline Self-Reported Grades 2.861.0 2.460.9 2.061.3 2.47 .291 .32 .572
Baseline Self-Reported School QOL 66.3622.5 66.7612.5 55.8628.7 .63 .728 .32 .572
Baseline Parent-Reported School QOL 64.7627.5 56.4616.8 56.7640.7 .57 .751 .00 .999
Baseline Age-Normed Vigilance (z) 20.1161.26 0.3260.79 21.6162.59 3.83 .148 3.07 .080
Weeks Baseline to Follow-up 38.066.7 35.769.6 36.4615.6 2.82 .244 .33 .568
Optimized PAP Pressure --- 10.062.7 9.262.2 --- --- .19 .665
% PAP Adherence --- 5.967.8 56.8622.3 --- --- 9.10 .003
PRIMARY OUTCOMES:
Change in School Performance and Attention (Positive Values Indicate Improvements from Baseline to Follow-up)
Change in Self-Reported Grades 2.106.60 2.596.81 .506.45 7.18 .028 6.25 .012
Change in Self-Reported School QOL 2.3614.3 215.8613.2 2.5610.8 6.24 .044 4.47 .034
Change in Parent-Reported School QOL 7.7617.2 29.2613.9 12.5617.1 4.79 .091 3.73 .054
Change in Age-Normed Vigilance .2361.4 2.646.75 1.261.5 6.68 .035 3.78 .052
Group data refer to percents for sex and race, and mean 6 standard deviation for all others. Body Mass Index (BMI) = (mass in kg)/(height in m)
2. Age- and sex-adjusted
BMI conversion made per US Centers for Disease Control and Prevention. Obstructive Index = OSA severity as indexed by the number of obstructive apneas +
hypopneas per hour of sleep (see [3]). QOL = Quality of Life.
doi:10.1371/journal.pone.0016924.t001
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baseline functioning, this may have been due to inadequate
statistical power for cross-sectional analyses; in a larger sample,
baseline characteristics might prove to be significant predictors of
adherence and change in attention or scholastic performance. It is
also possible that unmeasured factors (e.g., family disorganization)
could confound results, or that adolescents who experienced initial
clinical improvements became more motivated to maintain or
increase PAP usage. An experimental trial, in which children with
known OSA are randomized to a PAP versus placebo (‘‘sham-
PAP’’) condition could help to eliminate confounds, but would still
need to deal with issues of adherence in the treatment arm and
would further require careful ethics consideration.
Although these limitations suggest a need for study replication
and extension in larger-scale studies, present findings may have
important clinical and public health implications. Adolescent
obesity has reached epidemic prevalence, placing many adoles-
cents at high risk for OSA [10] while simultaneously reducing the
success and increasing the complication rates associated with
airway surgery [6]. The scholastic impact of untreated OSA may
be of particular concern during adolescence, when school
performance more clearly predicts long-term outcomes than at
any prior developmental stage [3]. Conversely, successful
treatments during adolescence may have particularly high long-
term yield [15]. Findings from this study are consistent with
clinical recommendations for PAP treatment in adolescents with
OSA [5,11], and add an empirical foundation for clinicians to use
while communicating the importance of PAP therapy adherence
to patients and their families.
Because PAP adherence rates are low and adolescents who are
non-adherent remain at risk for significant medical and neurobe-
havioral morbidity, it is imperative that future research identify the
key obstacles to PAP adherence among adolescents. Considerable
progress has been made in identifying predictors of PAP
adherence in adults [16]. However, such predictors are likely to
be unique in pediatric populations due to developmental factors,
including the adolescent transition from parent-directed care to
patient-directed care. Based upon the minimal pediatric data
available, neither demographic factors nor the mode of PAP
delivery (single-level versus bi-level) appear to be major adherence
predictors, though some aspects of pre-treatment disease severity
may predict adherence [5,11]. In adolescents, correlates of PAP
Figure 1. Change over time in sustained attention/vigilance and academic performance among adolescents who used PAP, those
who were non-adherent to PAP treatment, and untreated controls. Error bars reflect the standard error of the mean. Higher scores denote
better functioning. Self-reported academic grades are expressed according to the US 4-point convention (max =4.0; see [3]). Vigilance is expressed as
an age-adjusted z-score compared to published norms [14]. Academic quality of life is expressed on the 0–100 scale used by the Peds-QL, on which
completely healthy individuals average around 80 [13].
doi:10.1371/journal.pone.0016924.g001
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that adolescent adherence levels are related to changes in
functional outcomes, highlight the need for additional work in
this area so that novel therapies that promote PAP adherence can
be developed and tested.
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